CYP24A1, which reduces 1,25-OH-D to 25-OH-D, was shown to be present in 50% of breast cancer samples, whereas its expression is low in normal breast tissue (excluding luminal epithelial progenitors). Here, CYP24A1 is linked to breast carcinoma.